InfuSystem Holdings, Inc. (INFU)
NYSEAMERICAN: INFU · IEX Real-Time Price · USD
8.12
+0.51 (6.70%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Company Description

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada.

The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others.

In addition, it offers local and field-based customer support, as well as operates pump service and repair centers.

The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

InfuSystem Holdings, Inc.
InfuSystem Holdings logo
Country United States
Founded 2005
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 499
CEO Richard A. DiIorio

Contact Details

Address:
3851 West Hamlin Road
Rochester Hills, Michigan 48309
United States
Phone (248) 291-1210
Website infusystem.com

Stock Details

Ticker Symbol INFU
Exchange NYSEAMERICAN
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001337013
CUSIP Number 45685K102
ISIN Number US45685K1025
Employer ID 20-3341405
SIC Code 3841

Key Executives

Name Position
Richard A. DiIorio Chief Executive Officer and Director
Carrie A. Lachance B.S.N., M.B.A., R.N. President, Chief Operating Officer and Director
Barry G. Steele Executive Vice President and Chief Financial Officer
Addam Chupa Executive Vice President and Chief Information Officer
Jerod Funke Executive Vice President and Chief Human Resources Officer
Jeanie Latz Corporate Secretary

Latest SEC Filings

Date Type Title
Apr 23, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 10, 2024 DEF 14A Other definitive proxy statements
Apr 10, 2024 10-K Annual Report
Apr 3, 2024 8-K Current Report
Mar 14, 2024 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Mar 14, 2024 8-K Current Report
Mar 8, 2024 8-K Current Report
Mar 8, 2024 8-K Current Report
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals